West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
1.827B1.827B1.978B1.823B1.681B1.458B1.538B1.551B1.483B
521.400M521.400M791.300M628.500M509.700M404.200M484.600M490.900M446.200M
Short-Term Investments
0.000.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
521.400M521.400M791.300M628.500M509.700M404.200M484.600M490.900M446.200M
685.600M685.600M574.400M625.000M582.400M543.600M552.500M524.300M479.400M
452.600M452.600M443.900M438.000M421.100M388.700M377.000M401.200M419.200M
4.110B4.110B4.270B4.106B3.953B3.618B3.643B3.675B3.489B
3.333B3.333B1.843B1.838B1.826B1.735B1.686B1.679B1.604B
109.200M109.200M110.000M110.600M110.900M107.500M106.100M108.800M107.300M
Intangible Assets
7.000M7.000M7.700M8.900M9.700M10.000M10.800M12.300M12.900M
Long-Term Investments
209.200M209.200M212.300M220.900M224.700M211.900M202.100M217.500M198.200M
Total Current Liabilities
674.000M674.000M654.900M635.400M604.600M526.700M550.400M516.500M633.700M
252.300M252.300M253.700M255.800M239.000M228.400M239.300M224.300M211.700M
0.000.000.000.000.000.000.000.00132.900M
Total Liabilities
1.119B1.119B1.094B1.054B1.024B935.100M961.100M923.000M912.600M
202.800M202.800M202.800M202.700M202.600M202.600M202.600M202.600M72.900M
316.200M316.200M321.100M297.600M303.300M303.200M302.300M304.800M310.700M
Net Debt (Cash)
-205.200M-205.200M-470.200M-330.900M-206.400M-101.000M-182.300M-186.100M-135.500M
2.990B2.990B3.176B3.051B2.929B2.683B2.682B2.752B2.577B
Common Stock
18.800M18.800M18.800M18.800M18.800M18.800M18.800M18.800M18.800M
4.476B4.476B4.375B4.262B4.139B4.031B3.957B3.857B3.721B
2.712.713.022.872.782.772.793.002.34
0.110.110.100.100.100.110.110.110.12

Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
1.978B1.538B1.936B1.919B1.742B1.374B1.059B894.400M
791.300M484.600M853.900M894.300M762.600M615.500M439.100M337.400M
Short-Term Investments
0.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
791.300M484.600M853.900M894.300M762.600M615.500M439.100M337.400M
574.400M552.500M512.000M507.400M489.000M385.300M319.300M288.200M
443.900M377.000M434.700M414.800M378.400M321.300M235.700M214.500M
4.270B3.643B3.829B3.617B3.314B2.794B2.341B1.592B
1.843B1.686B1.512B1.263B1.127B1.012B909.400M822.000M
110.000M106.100M108.500M107.300M109.900M111.100M107.800M105.800M
Intangible Assets
7.700M10.800M15.100M18.400M23.000M30.500M29.800M20.400M
Long-Term Investments
212.300M202.100M210.000M204.900M207.700M214.700M192.700M91.200M
Total Current Liabilities
654.900M550.400M671.800M519.000M594.100M503.400M341.600M283.700M
253.700M239.300M242.400M215.400M232.200M213.100M156.800M130.400M
22.700M18.800M134.000M2.200M44.200M2.300M2.300M100K
Total Liabilities
1.094B961.100M948.500M931.900M978.400M939.300M768.200M582.600M
298.400M202.600M72.800M206.700M208.800M252.900M255.000M196.000M
416.700M305.300M309.000M317.900M325.300M325.700M329.300M196.100M
Net Debt (Cash)
-374.600M-179.300M-544.900M-576.400M-437.300M-289.800M-109.800M-141.300M
3.176B2.682B2.881B2.685B2.335B1.855B1.573B1.396B
Common Stock
18.800M18.800M18.800M18.800M18.800M18.800M18.800M18.800M
4.375B3.957B3.523B2.988B2.457B1.847B1.549B1.353B
3.022.792.883.702.932.733.103.15
0.130.110.110.120.140.180.210.14

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green